Home
Perceptive Advisors reported a 7.5% stake in Contineum Therapeutics CTNM · 1,441,249 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.5%
- Last report
- 5.6% · filed 25/02/14
- Shares held
- 1,441,249 sh
- Class
- Class A Common Stock, par value $0.001 per share
- Holder
- Perceptive Advisors
- Event date
- 25/03/31
- Filed
- 25/05/15
7.5% stake · +1.9pp from the last report
- Stake
- 7.5%
- Last report
- 5.6%
- Since last report
- +1.9pp
Contineum Therapeutics trades, last 26 weeks
What else happened in Contineum Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Perceptive Advisors's other 5% stake reports
- Perceptive Advisors
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
5.3% stake
5,536,629 sh
5.3% stake
Filed 09/23
- Perceptive Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7.6% stake
11,418,016 sh
7.6% stake
Filed 08/27
- Perceptive Advisors
5% stakeLeonaBio
5% stakeLeonaBio
LONA
19.99% stake
1,889,403 sh
19.99% stake
Filed 08/25
- Perceptive Advisors
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
11.2% stake
12,046,579 sh
11.2% stake
Filed 08/14
- Perceptive Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
4.9% stake
4,319,496 sh
4.9% stake
Filed 08/14
